Monthly Archives: February 2019

Cantor Fitzgerald Keeps a Buy Rating on Celgene (CELG)

Cantor Fitzgerald analyst Alethia Young reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $100. The company’s shares closed yesterday at $83.12. Young wrote: “: Reiterate Overweight rating and $100 price target.

Cowen & Co. Keeps a Buy Rating on TFI International Inc (TFII)

Yesterday, an analyst has provided a rating update for TFI International Inc (TFII – Research Report). Analyst Jason Seidl from Cowen & Co. rated TFI International Inc (TFII – Research Report) a Buy, setting a C$55 price target. According to

Nordstrom Inc (JWN) Receives a Hold from Guggenheim

Guggenheim analyst Robert Drbul maintained a Hold rating on Nordstrom Inc (JWN – Research Report) yesterday. The company’s shares closed yesterday at $47.28. Drbul observed: “We view JWN’s top-line strategy (brands, e-comm, local market) and profitability initiatives positively, but believe

The EVP; Pres. – International of SBA Communications Corporation is Exercising Options

Yesterday it was reported that the EVP; Pres. – International of SBA Communications Corporation (SBAC – Research Report), Kurt Bagwell, exercised options to sell 92,154 SBAC shares at $111.95 a share, for a total transaction value of $16.76M. Following Kurt

Calfrac Well Services (CFW) Gets a Buy Rating from BMO Capital

Calfrac Well Services (CFW – Research Report), the Materials sector company was revisited yesterday, and remains undervalued for at least one analyst on the street. Analyst Michael Mazar from BMO Capital rated Calfrac Well Services (CFW – Research Report) a

Oppenheimer Thinks Novavax’s Stock is Going to Recover

Oppenheimer analyst Kevin Degeeter maintained a Buy rating on Novavax (NVAX – Research Report) yesterday and set a price target of $1.50. The company’s shares closed yesterday at $0.71, close to its 52-week low of $0.67. Degeeter noted: “While we